| 1989 |
Magaziner J, Simonsick EM, Kashner TM, Hebel JR, Kenzora JE. Survival experience of aged hip fracture patients. Am J Public Health. March 1989;79(3):274-278. |
25 |
24 |
| 1995 |
Flahiff CM, Brooks AT, Hollis JM, Vander Schilden JL, Nicholas RW. Biomechanical analysis of patellar tendon allografts as a function of donor age. Am J Sports Med. May–June 1995;23(3):354-358. |
6 |
6 |
| 2000 |
Glorieux FH, Travers R, Taylor A, Bowen JR, Rauch F, Norman M, Parfitt AM. Normative data for iliac bone histomorphometry in growing children. Bone. February 2000;26(2):103-109. |
23 |
13 |
| 2000 |
Rauch F, Travers R, Parfitt AM, Glorieux FH. Static and dynamic bone histomorphometry in children with osteogenesis imperfecta. Bone. June 2000;26(6):581-589. |
28 |
24 |
| 2000 |
Parfitt AM, Travers R, Rauch F, Glorieux FH. Structural and cellular changes during bone growth in healthy children. Bone. October 2000;27(4):487-494. |
27 |
22 |
| 2002 |
Parfitt AM. Targeted and nontargeted bone remodeling: relationship to basic multicellular unit origination and progression. Bone. January 2002;30(1):5-7. |
50 |
48 |
| 2002 |
Parfitt AM. Misconceptions (2): turnover is always higher in cancellous than in cortical bone. Bone. June 2002;30(6):807-809. |
40 |
40 |
| 2002 |
Qiu S, Rao DS, Palnitkar S, Parfitt AM. Age and distance from the surface but not menopause reduce osteocyte density in human cancellous bone. Bone. August 2002;31(2):313-318. |
25 |
23 |
| 2003 |
Ciarelli TE, Fyhrie DP, Parfitt AM. Effects of vertebral bone fragility and bone formation rate on the mineralization levels of cancellous bone from white females. Bone. March 2003;32(3):311-315. |
42 |
37 |
| 2005 |
Qiu S, Rao DS, Fyhrie DP, Palnitkar S, Parfitt AM. The morphological association between microcracks and osteocyte lacunae in human cortical bone. Bone. July 2005;37(1):10-15. |
33 |
32 |
| 2007 |
Jilka RL. Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone. June 2007;40(6):1434-1446. |
25 |
25 |
| 2009 |
Ciarelli TE, Tjhia C, Rao S, Qiu S, Parfitt M, Fyhrie DP. Trabecular packet-level lamellar density patterns differ by fracture status and bone formation rate in white females. Bone. November 2009;45(5):903-908. |
12 |
9 |
| 2020 |
Menon LP, Weinstein RS. Iron replacement ameliorates hypophosphatemia in autosomal dominant hypophosphatemic rickets: a review of the role of iron. Bone. February 2020;131:115137. |
2 |
2 |
| 2021 |
Whyte MP, Aronson J, McAlister WH, Weinstein RS, Wenkert D, Clements KL, Gottesman GS, Madson KL, Stolina M, Bijanki VN, Plotkin H, Huskey M, Duan S, Mumm S. Coalescing expansile skeletal disease: delineation of an extraordinary osteopathy involving the ifitm5 mutation of osteogenesis imperfecta type V. Bone. April 2021;145:115835. |
0 |
0 |
| 2021 |
Mohan M, Kumar M, Samant R, Van Hemert R Jr, Tian E, Desai S, van Rhee F, Thanendrarajan S, Schinke C, Suva LJ, Sharma S, Milad M, Kendrick S, Zangari M. Bone remineralization of lytic lesions in multiple myeloma: the Arkansas experience. Bone. May 2021;146:115876. |
0 |
0 |
| 2022 |
Chen J-R, Lazarenko OP, Blackburn ML. GPR109A gene deletion ameliorates gonadectomy-induced bone loss in mice. Bone. August 2022;161:116422. |
0 |
0 |
| 2022 |
Sherman KM, Williams DK, Welsh CA, Cooper AM, Falck A, Huggins S, Bokhari RS, Gaddy D, McKelvey KD, Dawson LA, Suva LJ. Low bone mass and impaired fracture healing in mouse models of Trisomy21 (Down syndrome). Bone. September 2022;162:116471. |
0 |
0 |
| 2023 |
Cassidy A, Onal M, Pelletier S. Novel methods for the generation of genetically engineered animal models. Bone. February 2023;167:116612. |
1 |
1 |
| 2023 |
Palmieri M, Joseph TE, O'Brien CA, Gomez-Acevedo H, Kim H-N, Manolagas SC, Ambrogini E. Deletion of the scavenger receptor Scarb1 in myeloid cells does not affect bone mass. Bone. May 2023;170:116702. |
0 |
0 |
| 2023 |
Yoon J, Kaya S, Matsumae G, Dole N, Alliston T. MiR181a/b-1 controls osteocyte metabolism and mechanical properties independently of bone morphology. Bone. October 2023;175:116836. |
0 |
0 |
| 2023 |
Palmieri M, Joseph TE, O'Brien CA, Gomez-Acevedo H, Kim H-N, Manolagas SC, Ambrogini E. Retraction notice to “Deletion of the scavenger receptor Scarb1 in myeloid cells does not affect bone mass” [Bone 170(2023) 116702]. Bone. November 2023;176:116885. |
0 |
0 |
| 2023 |
Korff C, Adaway M, Atkinson EG, Horan DJ, Klunk A, Silva BS, Bellido T, Plotkin LI, Robling AG, Bidwell JP. Loss of Nmp4 enhances bone gain from sclerostin antibody administration. Bone. December 2023;177:116891. |
0 |
0 |
| 1990 |
McDevitt CA, Webber RJ. The ultrastructure and biochemistry of meniscal cartilage. Clin Orthop Relat Res. March 1990;252:8-18. |
43 |
43 |
| 2005 |
Bellido T, Ali AA, Gubrij I, Plotkin LI, Fu Q, O’Brien CA, Manolagas SC, Jilka RL. Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. Endocrinology. November 2005;146(11):4577-4583. |
43 |
34 |
| 2000 |
Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev. April 2000;21(2):115-137. |
128 |
124 |
| 2010 |
Manolagas SC. From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev. June 2010;31(3):266-300. |
25 |
24 |
| 2008 |
Robling AG, Niziolek PJ, Baldridge LA, Condon KW, Allen MR, Alam I, Mantila SM, Gluhak-Heinrich J, Bellido TM, Harris SE, Turner CH. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J Biol Chem. February 29, 2008;283(9):5866-5875. |
136 |
126 |
| 1998 |
Jilka RL, Weinstein RS, Bellido T, Parfitt AM, Manolagas SC. Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J Bone Miner Res. May 1998;13(5):793-802. |
33 |
26 |
| 2003 |
Qiu S, Rao DS, Palnitkar S, Parfitt AM. Reduced iliac cancellous osteocyte density in patients with osteoporotic vertebral fracture. J Bone Miner Res. September 2003;18(9):1657-1663. |
22 |
22 |
| 2005 |
Riggs BL, Parfitt AM. Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling. J Bone Miner Res. February 2005;20(2):177-184. |
33 |
30 |
| 2006 |
Aguirre JI, Plotkin LI, Stewart SA, Weinstein RS, Parfitt AM, Manolagas SC, Bellido T. Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss. J Bone Miner Res. April 2006;21(4):605-615. |
65 |
60 |
| 2010 |
Shane E, Burr D, Ebeling PR, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster D, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Koval K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O'Keefe R, Papapoulos S, Sen HT, van der Meulen MCH, Weinstein RS, Whyte M. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. November 2010;25(11):2267-2294. |
62 |
45 |
| 2013 |
Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR, Parfitt AM. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. January 2013;28(1):2-17. |
224 |
218 |
| 2013 |
Spatz JM, Ellman R, Cloutier AM, Louis L, van Vliet M, Suva LJ, Dwyer D, Stolina M, Ke HZ, Bouxsein ML. Sclerostin antibody inhibits skeletal deterioration due to reduced mechanical loading. J Bone Miner Res. April 2013;28(4):865-874. |
23 |
19 |
| 2014 |
Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster DW, Ebeling PR, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O’Keefe R, Papapoulos S, Howe TS, van der Meulen MCH, Weinstein RS, Whyte MP. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. January 2014;29(1):1-23. |
58 |
42 |
| 2020 |
Ponte F, Kim H, Iyer S, Han L, Almeida M, Manolagas SC. Cxcl12 deletion in mesenchymal cells increases bone turnover and attenuates the loss of cortical bone caused by estrogen deficiency in mice. J Bone Miner Res. August 2020;35(8):1441-1451. |
1 |
1 |
| 2021 |
Palmieri M, Kim H, Gomez‐Acevedo H, Que X, Tsimikas S, Jilka RL, Manolagas SC, Witztum JL, Ambrogini E. A neutralizing antibody targeting oxidized phospholipids promotes bone anabolism in chow‐fed young adult mice. J Bone Miner Res. January 2021;36(1):170-185. |
1 |
0 |
| 2021 |
Sato AY, Pellegrini GG, Cregor M, McAndrews K, Choi RB, Maiz M, Johnson O, McCabe LD, McCabe GP, Ferruzzi MG, Lila MA, Peacock M, Burr DB, Nakatsu CH, Weaver CM, Bellido T. Skeletal protection and promotion of microbiome diversity by dietary boosting of the endogenous antioxidant response. J Bone Miner Res. April 2021;36(4):768-778. |
0 |
0 |
| 2023 |
Atkinson EG, Adaway M, Horan DJ, Korff C, Klunk A, Orr AL, Ratz K, Bellido T, Plotkin LI, Robling AG, Bidwell JP. Conditional loss of Nmp4 in mesenchymal stem progenitor cells enhances PTH-induced bone formation. J Bone Miner Res. January 2023;38(1):70-85. |
0 |
0 |
| 2023 |
Xu X, Yang H, Bullock WA, Gallant MA, Ohlsson C, Bellido TM, Main RP. Osteocyte estrogen receptor β (Ot-ERβ) regulates bone turnover and skeletal adaptive response to mechanical loading differently in male and female growing and adult mice. J Bone Miner Res. January 2023;38(1):186-197. |
0 |
0 |
| 2023 |
Delgado-Calle J, Roodman GD. Doubling down on Wnt signaling to overcome myeloma bone disease. J Bone Miner Res. June 2023;38(6):812-813. |
0 |
0 |
| 1998 |
Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: potential mechanisms of their deleterious effects on bone. J Clin Invest. July 15, 1998;102(2):274-282. |
52 |
44 |
| 1999 |
Jilka RL, Weinstein RS, Bellido T, Roberson P, Parfitt AM, Manolagas SC. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest. August 1999;104(4):439-446. |
60 |
50 |
| 1999 |
Plotkin LI, Weinstein RS, Parfitt AM, Roberson PK, Manolagas SC, Bellido T. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest. November 1999;104(10):1363-1374. |
45 |
37 |
| 2013 |
Jilka RL. The relevance of mouse models for investigating age-related bone loss in humans. J Gerontol A Biol Sci Med Sci. October 2013;68(10):1209-1217. |
35 |
35 |
| 1985 |
Webber RJ, Harris MG, Hough AJ Jr. Cell culture of rabbit meniscal fibrochondrocytes: proliferative and synthetic response to growth factors and ascorbate. J Orthop Res. 1985;3(1):36-42. |
26 |
26 |
| 2023 |
Siddicky S, Eckels J, Rabenhorst B, Mannen E. Ultrasonographic evaluation of infant hips in the Pavlik harness compared to body-worn commercial baby carriers. J Orthop Res. November 2023;41(11):2495-2500. |
0 |
0 |
| 2011 |
Xiong J, Onal M, Jilka RL, Weinstein RS, Manolagas SC, O'Brien CA. Matrix-embedded cells control osteoclast formation. Nat Med. November 2011;17(10):1235-1242. |
72 |
69 |
| 1995 |
Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling: emerging insights into the pathophysiology of osteoporosis. NEJM. February 2, 1995;332(5):305-311. |
35 |
32 |
| 2009 |
Boskey AL, Spevak L, Weinstein RS. Spectroscopic markers of bone quality in alendronate-treated postmenopausal women. Osteoporos Int. May 2009;20(5):793-800. |
30 |
22 |